HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failure.

AbstractBACKGROUND:
The pathophysiologic and potential therapeutic role of selectins in renal ischemia-reperfusion injury (IRI) is not fully understood, due in part to redundancy in the roles of individual selectins. We hypothesized that blockade of ligands for all three selectins using a novel small molecule (TBC-1269) would improve the course of renal IRI by overcoming redundancy issues. This was investigated in a rat model of renal IRI.
METHODS:
Rats were treated with TBC-1269 either during or post-IRI. The effects of TBC-1269 were investigated in two models of renal IRI: moderate IRI (30 minutes bilateral renal artery clamping) and severe IRI (45 minutes clamping). The combination of anti-E- and anti-P-selectin antibodies also was investigated in rats subjected to moderate IRI. Renal function, histological injury and mortality were assessed.
RESULTS:
Rats treated with TBC-1269 during moderate IRI showed significantly reduced serum creatinine (SCr) and tubular necrosis post-ischemia compared to control animals. By contrast, delayed treatment (post-IRI) did not show a reduction in SCr. In rats with severe IRI, TBC-1269 treatment during IRI significantly reduced mortality at 48 hours post-ischemia. Rats with moderate IRI and treated with the combination of anti-E- and anti-P-selectin antibodies showed significantly reduced SCr compared to control rats at 24 hours post-ischemia.
CONCLUSIONS:
Small molecule selectin ligand inhibition provides a novel and effective approach to attenuate ischemic acute renal failure. Timing of treatment is crucial to success.
AuthorsT Nemoto, M J Burne, F Daniels, M P O'Donnell, J Crosson, K Berens, A Issekutz, B L Kasiske, W F Keane, H Rabb
JournalKidney international (Kidney Int) Vol. 60 Issue 6 Pg. 2205-14 (Dec 2001) ISSN: 0085-2538 [Print] United States
PMID11737594 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antibodies
  • Biphenyl Compounds
  • E-Selectin
  • Mannosides
  • P-Selectin
  • Selectins
  • bimosiamose disodium
  • Peroxidase
  • Mannose
Topics
  • Acute Kidney Injury (mortality, physiopathology)
  • Animals
  • Antibodies (pharmacology)
  • Biphenyl Compounds (pharmacology)
  • CD4 Lymphocyte Count
  • E-Selectin (immunology)
  • Immunohistochemistry
  • Ischemia (complications, physiopathology)
  • Kidney (drug effects, pathology, physiopathology)
  • Kidney Tubules (pathology)
  • Male
  • Mannose (analogs & derivatives)
  • Mannosides (pharmacology)
  • P-Selectin (immunology)
  • Peroxidase (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Renal Circulation
  • Selectins (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: